Organic anions are taken up from the blood into proximal tubule cells by organic anion transporters 1 and 3 (OAT1 and OAT3) in exchange for dicarboxylates. The released dicarboxylates are recycled by the sodium dicarboxylate cotransporter 3 (NaDC3). In this study, we tested the substrate specificities of human NaDC3, OAT1, and OAT3 to identify those dicarboxylates for which the three cooperating transporters have common high affinities. All transporters were stably expressed in HEK293 cells, and extracellularly added dicarboxylates were used as inhibitors of
EFFICIENT EXCRETION OF ANIONIC endogenous waste products and exogenous compounds including drugs and toxins is an important task of the kidneys. Many organic anions (OA) undergo active trans-cellular secretion in renal proximal tubules, involving OA uptake across the basolateral membrane and OA release across the luminal membrane of proximal tubule cells. The uptake of OA from blood across the basolateral membrane into tubule cells is remarkable in several ways. First, OA uptake is considered the rate-limiting step in secretion; second, the uptake occurs against an opposing intracellular negative membrane potential difference; third, a multitude of chemically different OA is accepted as substrates for secretion (8, 30, 36) . The mechanism by which OA overcome the opposing driving force during basolateral uptake was clarified in studies with basolateral membrane vesicles isolated from rat kidneys. Shimada et al. (29) and Pritchard (25) suggested the cooperation of two transporters: a sodium-driven dicarboxylate cotransporter and an OA/dicarboxylate exchanger.
As regards the molecular identity of these cooperating transporters, the sodium-dicarboxylate cotransporter 3 (NaDC3, SLC13A3) takes up dicarboxylates into the cells and thus provides substrates for exchange against extracellular OA through the organic anion transporters 1 and 3 (OAT1, SLC22A6; and OAT3, SLC22A8). NaDC3 was cloned from human, rat, mouse, and winter flounder and found to be expressed in kidneys, liver, placenta, and brain (20) . NaDC3 has a high affinity for succinate and ␣-ketoglutarate, and it translocates three sodium ions with a divalent dicarboxylate, leading to inward currents during uptake (9, 21, 31) . OAT1 was cloned from human, monkey, pig, rabbit, rat, and mouse. Expression of OAT1 occurred mainly in kidneys where it is located in the basolateral membrane of proximal tubule cells (8, 30, 36) . Cloned OAT1 interacted with numerous drugs and toxins, revealing its importance for renal excretion of xenobiotics (8, 30, 36) . The closely related OAT3 was cloned from human, monkey, pig, rabbit, rat, and mouse. In all species, OAT3 expression was highest in the kidneys and it was localized to the basolateral membrane of proximal tubules. Heterologously expressed OAT3 showed a wide substrate specificity overlapping with that of OAT1 (8, 30, 36) . The differential contribution of OAT1 and OAT3 to renal OA secretion has been elucidated with knockout mice (12, 32, 35, 37) .
Earlier studies with rat renal proximal tubules in vivo revealed dicarboxylates as inhibitors of the basolateral uptake of a prototypic OA, p-aminohippurate (PAH) (33) . Thereby, dicarboxylates with a backbone of at least five carbons exhibited a high affinity for the so-called PAH system. Since, as it became known later, at least two transporters contributed to PAH uptake in these in vivo studies, it is not clear whether the observed dicarboxylate specificity can be attributed to OAT1 or OAT3 or to both. Cloned rat OAT1 (34) Effective cooperation of NaDC3 and OAT1/OAT3 requires the presence of dicarboxylates accepted with high affinity by all three transporters. The aim of this study was to provide quantitative data for the interaction of dicarboxylates with human NaDC3, OAT1, and OAT3. To allow for direct comparison of IC 50 values, all transporters were stably transfected in HEK293 cells. Whereas HEK-OAT1 and HEK-OAT3 cells were previously established (3), we describe here the stable expression of human NaDC3 in HEK cells. We then compared the IC 50 values for a series of dicarboxylates on NaDC3, OAT1, and OAT3 and found that the C5 dicarboxylate ␣-ketoglutarate is most suited for the cooperative action of these transporters. The dependence of apparent affinity of NaDC3 on the length of aliphatic dicarboxylates is different from that of OAT1 and OAT3, suggesting binding sites of different substrate recognition properties. A similar preference by OAT1 and OAT3 for dicarboxylates of different lengths, on the other side, indicates closely related substrate binding sites, albeit with different accessibilities.
MATERIALS AND METHODS
Transfected cells. Human NaDC3, OAT1, and OAT3 (GeneBank accession numbers: AF154121, AF097490, and BI760120, respectively) were obtained from Resource Center for Genome Research (RZPD, Berlin, Germany). Stably transfected human epithelial kidney cells T-REX-HEK293-hOAT1, -HEK293-hOAT3, and -HEK293-NaDC3 were established by using the Flp-In expression system (Invitrogen, Darmstadt, Germany) as previously described (3). Cells were selected by hygromycine (10 g/ml) and grown in flasks in high-glucose DMEM medium (Invitrogen) supplemented with 10% fetal calf serum (Invitrogen), 1% penicillin/streptomycin, and blasticidine (5 mg/l; all antibiotics from Sigma, Deisenhofen, Germany). Control cells were transfected with the vector alone. Cultures were seeded at a density of 2 ϫ 10 5 cells/well and maintained in humidified atmosphere that contained 5% CO 2 at 37°C.
Solutions. A standard mammalian Ringer solution (MRi) was used for the uptake experiments. MRi contained (in mM) 130 NaCl, 4 KCl, 1 CaCl 2, 1 MgSO4, 1 NaH2PO4, 20 HEPES, and 18 glucose at pH 7.4. Dicarboxylates were added at various concentrations to determine the IC 50 values. Nominal sodium-free conditions were obtained by replacing NaCl by N-methyl-D-glucamine chloride. Chemicals were purchased from Sigma or Applichem (Darmstadt, Germany) and were of analytical grade.
Antibodies. The immune serum against human NaDC3 was raised in rabbits against the synthetic peptide (ARAVIREEYQNLGPIK), corresponding to 16 amino acids of the internal region of NaDC3 (Eurogentec, Seraing, Belgium). Peptide-specific antibodies (NaDC3-Ab) were affinity purified from the immune serum on an affinity column. The specificity of NaDC3-Ab was analyzed by Western blotting of total cell membranes isolated from the NaDC3 stably transfected HEK293 cells, and by immunocytochemistry of the same cells. The vector-transfected HEK293 cells were used as a negative control. The secondary antibodies, i.e., the CY3-labeled (GARCY3) and alkaline phosphatase-labeled (GARAP) goat antirabbit IgG, were purchased from Jackson Immuno Research Laboratories (West Grove, PA).
Immunocytochemistry. The vector-transfected (control cells) and NaDC3-transfected HEK293 cells were grown on coverslips in 24-well plates (Sarstedt, Nümbrecht, Germany). While still in wells, the cells were fixed with 4% p-formaldehyde (in PBS) for 30 min. The fixative was removed by suction, and the cells were rinsed with four abundant changes of PBS. The cells were then covered with 10 mM citrate buffer, pH 3, and heated in a microwave oven for 20 min at 800 W (4 cycles, 5 min each) to retrieve the antibody-binding sites. After cooling down for 20 min at room temperature in the same buffer, the cells were rinsed with PBS (3 times 5 min) and used in immunostaining procedure, as described in detail for our recent study of OAT2 expression in rat and mouse kidneys (18) . Briefly, following blocking with 1% bovine serum albumin (in PBS) for 30 min, the cells were incubated with NaDC3-Ab (dilution 1:150) at 4°C overnight, rinsed, incubated with GARCY3 (1.6 g/ml) for 60 min at room temperature, and rinsed again. The coverslip with the cells was then transferred on a microscope slide, overlayed with the fluorescence fading retardant Vectashield (Vector Laboratories, Burlingame, CA), veiled with a larger coverslip, and sealed with a nail polish. To test the staining specificity with the NaDC3-Ab, the cells were 1) stained with the primary antibody that had been blocked with the immunizing peptide (final concentration 0.5 mg/ml) for 4 h at room temperature before use in immunocytochemistry and 2) stained only with the secondary antibody (the primary antibody was omitted). The immunostaining was examined with an Opton III RS fluorescence microscope (Opton Feintechnik, Oberkochen, Germany) and photographed using a Spot RT Slider digital camera and software (Diagnostic Instruments, Sterling Heights, MI). The photos were imported into Adobe Photoshop 6.0 software for processing, assembling, and labeling. The same software was used for conversion of the CY3-related red fluorescence into black and white mode.
Preparation of total cell membranes, SDS-PAGE, and Western blotting. Cells grown in 150-mm disks were harvested, dispersed, and homogenized in ice-cold PBS by sonication. The homogenate was centrifuged at 6,000 g for 10 min. The pellet was discarded, and the supernatant was centrifuged at 150,000 g for 30 min. The resulting pellet was dispersed in PBS, the protein was measured by the Bradford assay (5), and the sample underwent SDS-PAGE and Western blotting as described in detail previously (18) . Briefly, total cell membranes (TCM) were mixed with nonreducing Laemmli buffer and denatured at 65°C for 15 min. Proteins were separated through 10% SDS-PAGE mini gels, and then electrophoretically wet-transferred to an Immobilon membrane (Millipore, Bedford, MA). The membrane was then blocked in blotto-buffer (5% nonfat dry milk, 0.15 M NaCl, 1% Triton X-100, 20 mM Tris·HCl, pH 7.4) for 1 h, incubated in the blotto-buffer containing the NaDC3-Ab (1:200) at 4°C overnight, rinsed, incubated at room temperature with GARAP (0.1 g/ml) for 60 min, rinsed, and the protein bands were visualized by the alkaline phosphatase activity-mediated reaction using 5-bromo-4-chloro-3-indolyl phosphate (1.65 mg/ml) and nitro blue tetrazolium (3.3 mg/ml) as indicators.
To show specific labeling, the NaDC3-Ab was preincubated with the immunizing peptide (final concentration, 0.5 mg/ml) for 4 h at room temperature before use in Western blotting. The relative molecular mass (Mr) of the labeled protein bands was estimated by using Protein Ladders (Fermentas, Ontario, Canada) as markers.
Deglycosylation assay. TCM isolated from the NaDC3-transfected HEK293 cells were incubated with the enzyme peptide-N-glycosidase F (PNGase F; Roche, Mannheim, Germany) according to the manufacturer's recommendations. The reaction mixture in a total volume of 20 l contained 16 units of PNGase F and 60 g TCM protein from the NaDC3-transfected cells. In the control sample, distilled water was substituted for PNGase F. The reaction was carried out for 1 h at 37°C. Thereafter, the samples underwent SDS-PAGE and Western blotting, as described above.
Tracer uptake experiments. NaDC3-, OAT1-, OAT3-, and vectortransfected HEK293 cells were harvested and plated into 24-well plastic dishes (Sarstedt) at a density of 2 ϫ 10 5 cells/well. Transport assays were performed 48 h after the cells were seeded in MRi. Cells were washed twice with 0.5 ml MRi and incubated for the time indicated in the Table 1 Statistics. The numeric data presented are means Ϯ SE of the number of cell preparations indicated in the table and figure legends. The kinetic parameters, K m and Vmax, for the uptake of succinate by NaDC3-transfected HEK293 cells were calculated by the equation For all kinetic experiments, the uptake into vector-transfected HEK293 cells was subtracted to obtain transporter-specific uptake. K m, Hill coefficient (see Fig. 2 ), IC50 values (Table 1) , and the linear regression (see Fig. 7 ) were calculated using the SigmaPlot10 software (Systat, Point Richmond, CA).
RESULTS
Immunochemical characterization of the NaDC3-transfected HEK293 cells. The NaDC3-transfected cells were characterized by immunocytochemistry and Western blotting using the NaDC3-Ab. As shown in Fig. 1A , the antibody stained the plasma membranes and the intracellular domain beneath the plasma membrane (NaDC3-transfected cells, Ab, and inset). This staining was absent following preincubation of the NaDC3-Ab with the immunizing peptide (Fig. 1A , NaDC3-transfected cells, AbϩP) and in the vector-transfected cells (Control cells, Ab). In Western blots of TCM isolated from control cells, no prominent protein band was labeled with the anti-NaDC3 antibody (Fig. 1B , Control, Ab), whereas, in TCM from the NaDC3-transfected cells, the antibody labeled two unsharp protein bands of ϳ85 and 55 kDa (Fig. 1B, NaDC3 , Ab). These bands were absent with the peptide-blocked antibody (Fig. 1B, NaDC3 , AbϩP). Since the two labeled bands may represent differentially glycosylated forms of NaDC3, TCM proteins from the NaDC3-transfected cells were deglycosylated with PNGase F, then separated by SDS-PAGE, and subsequently subjected to Western blotting using the antiNaDC3 antibody (Fig. 1C) . Following incubation without the enzyme, the control sample exhibited the expected two protein bands labeled with the NaDC3-Ab (-PNGase F). However, following the enzymatic digestion (ϩPGNase F), the upper ϳ85-kDa band was absent, and the antibody labeled two sharper protein bands of ϳ48 and ϳ56 kDa.
Functional characterization of NaDC3-transfected HEK293 cells. Succinate, the prototypical substrate of NaDC3, was used to demonstrate time-dependent uptake of [ 14 C]succinate in NaDC3-transfected cells (Fig. 2A) . Uptake of succinate increased with time, and virtually no succinate uptake was detected in vector-transfected cells over this time. To approach initial rate conditions, all further experiments were performed using an incubation time of 5 min. In NaDC3-transfected cells, succinate uptake saturated at succinate concentrations Ͼ50 M (Fig. 2B) , revealing a K m of 18.0 Ϯ 8.8 M and a V max of 208.0 Ϯ 31.5 pmol·5 min Ϫ1 ·well Ϫ1 . Uptake of succinate into vectortransfected cells was, even at succinate concentrations exceeding 50 M, negligible. Succinate uptake was sodium-dependent and showed a sigmoidal activation with a Hill coefficient of 2.1 Ϯ 0.9. Half maximal activation of succinate uptake by sodium occurred at a sodium concentration of 44.6 Ϯ 2.5 mM (Fig. 2C) .
Comparison of the dicarboxylate specificities of NaDC3-, OAT1-, and OAT3-transfected HEK293 cells. The chemical structures of the dicarboxylates used in this study are provided in Fig. 3 Figure 4 shows the results for the five-carbon dicarboxylates ␣-ketoglutarate and glutarate. In these representative experiments on NaDC3 (Fig. 4A) , ␣-ketoglutarate and glutarate inhibited succinate uptake by NaDC3 with IC 50 values of 69 and 138 M, respectively. OAT1 was half-maximally inhibited by 5.8 M ␣-ketoglutarate and 3.6 M glutarate (Fig. 4B) , and OAT3 by 117 M ␣-ketoglutarate and 88 M glutarate (Fig. 4C) , respectively.
The IC 50 values for all tested dicarboxylates are compiled in Table 1 Correlation of the chain length with the inhibitory potency. For easier visualization of the data presented in Table 1 , we plotted the log IC 50 against the chain length of the dicarboxylates (Fig. 5) . For NaDC3 (), log IC 50 steadily increased from succinate (4 carbons) to pimelate (7 carbons). Suberate (8 carbons) did not inhibit succinate uptake in NaDC3-transfected HEK293 cells and is not included. For OAT1 () and OAT3 (OE), log IC 50 values changed in parallel. Values sharply declined from succinate to glutarate and increased again at longer carbon chain lengths.
No significant correlation was observed in double-logarithmic plots of IC 50 values for succinate uptake into NaDC3-transfected HEK293 cells against those for PAH uptake in OAT1- (Fig. 6A) or for ES uptake in OAT3 (Fig. 6B )-transfected HEK293 cells: the r 2 values were 0.21 and 0.15 for NaDC3/OAT1 and NaDC3/OAT3, respectively. For NaDC3/ OAT1 as well as for NaDC3/OAT3, ␣-ketoglutarate and glutarate were identified as the best common inhibitors. A double-logarithmic plot of the IC 50 values with OAT1-and OAT3-transfected HEK293 cells revealed a linear correlation (r 2 0.99; Fig. 7 ). The regression line has a slightly smaller slope (0.91) than unity and has an intercept of 1.13, reflecting that dicarboxylates have in average a 13.4-fold higher affinity to OAT1 than to OAT3. Figure 7 also shows two clusters of IC 50 values: the C4 substrates maleate, fumarate, and succinate with relatively low affinity, and the C5-C7 substrates glutarate, ␣-ketoglutarate, adipate, and pimelate with relatively high affinity.
DISCUSSION
Based on earlier vesicle data (25, 29) , uptake of OA across the basolateral membrane of proximal tubule cells was proposed to be a tertiary active transport process. The Na ϩ -K ϩ -ATPase maintains an intracellular low-sodium concentration; the inward sodium gradient then drives three sodium ions energetically downhill and one dicarboxylate uphill through the cotransporter NaDC3 into the cells; finally, the intracellular dicarboxylates flow out downhill and drive uphill uptake of an OA through the exchangers OAT1 and OAT3. In energetic terms, one ATP is utilized per OA taken up from the blood. This arrangement of a cotransporter and one or more exchangers has been preserved during evolution from crab to human (26) , suggesting some as yet not fully understood advantages.
To efficiently drive OA transport, NaDC3 must take up a dicarboxylate that can easily bind from the cell inside to OAT1 and/or OAT3 to serve as a counter anion. This task is best achieved when the affinities of all involved transporters, NaDC3, OAT1, and OAT3, are in the same range for this or these dicarboxylates to ensure proper binding and translocation. To identify such dicarboxylates, we stably expressed human NaDC3, OAT1, and OAT3 in HEK293 cells. The affinities were checked in competition experiments by adding dicarboxylates to the incubation medium. Since all transporters were expressed in the same cell line, a direct comparison of affinities is possible. With OAT1 and OAT3, we determined the affinities to extracellular rather than to intracellular dicarboxylates, because a control of intracellular dicarboxylate concentrations is experimentally not possible. We assume, however, that the affinities of OAT1 and OAT3 to extracellular dicarboxylates are related to those at the intracellular side, at least with respect to the dicarboxylate selectivity.
For this study, human NaDC3 was stably expressed in HEK293 cells. Immunocytochemistry showed that the protein reached the plasma membrane. The two bands (ϳ85 and 55 kDa) in Western blots from TCM may reflect differentially glycosylated forms, because glycanase F treatment led to the disappearance of the 85-kDa band. Since the TCM preparation contained both plasma and intracellular membranes, the larger band may represent the fully glycosylated NaDC3 in the plasma membrane, whereas the smaller band(s) reflect unglycosylated or not completely glycosylated transporters in the endoplasmic reticulum and/or Golgi apparatus. Human NaDC3 is a protein with 11 transmembrane helices, an intracellular NH 2 and an extracellular COOH terminus (2) . The COOH terminus carries two potential N-glycosylation sites [Asn-586, Asn-596 (38) ] that are conserved in rat, mouse, and flounder NaDC3 (9, 16, 21, 31) . In rabbit NaDC1, the glycosylation affected membrane targeting (23) . It is likely that proper N-glycosylation serves a similar function in the human NaDC3. Fig. 3 . Chemical structures of the dicarboxylates used in the study. The structures were designed by using the program ChemWindow, SoftShell International, Grand Junction, CO.
The transfected clone used in this study coded for a fulllength human NaDC3 with 602 amino acids and a calculated molecular mass of 66,841 Da. However, following enzymatic deglycosylation, two bands with apparent molecular masses of Table 1 and plotted logarithmically against the length of the dicarboxylates. Fig. 6 . Correlation between log IC50 at NaDC3 with those at OAT1 (A) and OAT3 (B). Data from Table 1 are replotted in a double-logarithmic scale.
48 and 56 kDa were obtained in Western blots. As regards the upper 56-kDa band, the deglycosylated NaDC3 may run faster in the gel than anticipated from its mass, yielding an erroneously low molecular weight. The reason for the appearance of a second band is not known. Possibly, posttranslational modification and/or limited proteolysis may account for the observation of two bands.
Stably expressed human NaDC3 showed a saturable uptake of succinate with a K m of 18 M. This figure compares favorably with determinations in other expression systems such as Xenopus laevis oocytes [25 M (7)] and human retinal pigment epithelial cells [12.8 or 20.4 M (14, 38) ]. The stimulation by sodium of succinate uptake into stably transfected HEK cells was sigmoidal with a half-maximal activation effect at 44.6 mM and a Hill coefficient of 2.1, revealing a cooperative action of sodium ions on NaDC3. In another study on human NaDC3 expressed in human retinal pigment epithelial cells, activation by sodium was half-maximal at 49 mM sodium and the Hill coefficient was 2.7 (38) . Taken together, NaDC3 stably expressed in HEK cells shows functional properties well in line with results on human NaDC3 in another expression system.
Using dicarboxylates of different lengths, we found that NaDC3 has the highest affinity for the four-carbons dicarboxylate succinate. Thereby, the IC 50 (24 M) was very close to the K m (18 M) for succinate uptake determined with the same cells. Two other C4 dicarboxylates carrying a double bond had a lower (fumarate) or no measurable affinity (maleate), suggesting that position and distance of the carboxyl groups are critical for interaction. Likewise, the affinity decreased for longer dicarboxylates (glutarate to pimelate), indicating a strong preference of NaDC3 for saturated C4 dicarboxylates.
The five-carbon ␣-ketoglutarate exhibited a higher affinity than glutarate, suggesting that the ␣-carbonyl group facilitates binding to NaDC3. Comparable data were previously obtained with human (38) and rat (16) NaDC3, but quantitative data were so far not available.
The binding site for dicarboxylates in human NaDC3 is not known in detail. From extensive site-directed mutagenesis experiments on NaDC1, the low-affinity sodium-dicarboxylate cotransporter, it became apparent that several residues are involved in or are sensitive to dicarboxylate binding. These include, in rabbit NaDC1, Lys-84 (22) , four amino acids around Ser-260 (transmembrane helix H5), Arg-349 (H7), Asp-373 (H8), Glu-475 (H9) (summarized in Ref. 20) , and Ser-512 (H10) (19) . Thus, it is mainly the COOH-terminal part of NaDC3 that is involved in binding and transporting dicarboxylates. Since cationic residues may bind the negatively charged dicarboxylates, we previously mutated arginines and lysines situated inside or adjacent to the putative transmembrane helices of flounder NaDC3 (13) . With Lys-114 (H3) we found a residue that appeared to influence the number of sodium-binding sites. The replacement of Lys-36 by leucine (between H1 and H2) and of Lys-374 and Lys-375 by isoleucine (H8) resulted in a somewhat increased affinity for succinate; the changes were, however, not statistically significant (13) , leaving open where dicarboxylates bind to NaDC3. The lack of correlation between the IC 50 values for dicarboxylate interaction with NaDC3 and the respective values for OAT1 or OAT3 indicates completely different molecular requirements for dicarboxylate binding.
The interaction of dicarboxylates with human OAT1 was clearly different from that of NaDC3. The affinity increased sharply from succinate to glutarate and remained high for adipate, pimelate, and suberate. The C3 dicarboxylate malonate did not inhibit OAT1. Our data are in line with an earlier qualitative study on rat OAT1 with dicarboxylates of increasing lengths inhibiting PAH uptake (34) . Murine OAT1 showed the same dicarboxylate selectivity and, in a structure-activity relation approach, the charge distance turned out to be more important than hydrophobicity for the interaction of dicarboxylates with mouse OAT1 (15) .
For human OAT3, we found the same sequence of potency to inhibit transport. Malonate showed no inhibition, succinate had a very low affinity, followed by a large increase in affinity for glutarate. The affinity then decreased again for larger dicarboxylates. The very high correlation between the log IC 50 of OAT1 and the log IC 50 of OAT3 strongly suggests that the structural requirements of the binding sites in these two transporters are very similar. It appears, however, that the access of dicarboxylates to the binding site of OAT3 is restricted compared with OAT1: although OAT3 had the same dicarboxylate selectivity as OAT1, the IC 50 values were always higher than those of OAT1. Table 1 . Linear regression was performed using SigmaPlot software. Rat OAT3 was also inhibited by a series of dicarboxylates ranging from 5 to 9 carbons but IC 50 values were not reported (1) . As regards the in vivo studies in rat kidneys, succinate, glutarate, adipate, pimelate, and suberate inhibited PAH transport with K i values of 1.35 mM, 50 M, 60 M, 350 M, and 350 M, respectively (33) . With exception of succinate, the in vivo K i values are higher than those for human OAT1 and closer to those of human OAT3. Although K i values for rat OAT1 and OAT3 are not at hand, we assume that the in vivo data reflect a mixture of OAT1 and OAT3 with a relatively greater impact of OAT3. In support, the K m determined for PAH uptake in vivo was 80 M (33), which is closer to the data reported for OAT3 than for OAT1 (6) .
The binding sites for dicarboxylates in OAT1 or OAT3 are not known with certainty. Mutational analysis on the flounder OAT revealed two conserved cationic residues, Lys-394 (transmembrane helix H8) and Arg-478 (H11), as important for the interaction with dicarboxylates (39) . Mutants (K395A, R478D) transported PAH but were insensitive to cis-inhibition and trans-stimulation by glutarate. The replacement of the corresponding arginine in the middle of the 11th transmembrane helix (H11) of human OAT1 (Arg-466) by neutral (R466N) or acidic residues (R466D) abolished the interaction with glutarate, whereas the replacement by the cationic lysine (R466K) preserved glutarate binding (27) . These data suggested that a positive charge at position 466 is needed for binding and/or transport of dicarboxylates by human OAT1. In a three-dimensional homology model, human OAT1 showed a large cavity open to the intracellular side with Arg-466 positioned right at the opening of the putative binding pocket (24) . The model located another cationic residue, Lys-431 in H10, close to the binding pocket. Mutation of this residue inactivated OAT1 (24) , whereas, in human OAT3, the replacement of the corresponding Lys-419 abolished interaction with glutarate (summarized in Ref. 30) . Taken together, it appears that basic amino acid residues in trans-membrane helices 8, 10, and 11 play a role in dicarboxylate binding. In human OAT1, these residues are Lys-382 (H8), Lys-431 (H10), and Arg-466 (H11). The corresponding residues in human OAT3 are Lys-370 (H8), Lys-419 (H10), and Arg-454 (H11). At the level of the primary structure, these cationic amino acids have exactly the same distance to each other (see Fig. 8 ). Therefore, these residues may be situated at equivalent places in the three-dimensional transporter, explaining why the dicarboxylate specificity of OAT1 and OAT3 correlates highly as found in this study. The generally higher affinity of OAT1 may be due to a better accessibility of dicarboxylates to the binding site that is otherwise similar between OAT1 and OAT3.
As regards the functional coupling between NaDC3 and OAT1/OAT3, succinate and glutarate appear not ideal. Succinate has a high affinity for NaDC3 but very low affinities for OAT1 and OAT3. Thus, succinate, intracellularly accumulated by NaDC3, may not serve as a proper counterion for PAH and ES uptake through OAT1 and OAT3. Although glutarate has a relatively high affinity for all transporters, its plasma concentration (0.6 -2.9 M) (4) is low, probably leading to an inefficient intracellular accumulation of this dicarboxylate by NaDC3. Our results provide quantitative evidence for ␣-ketoglutarate being ideal for the functional coupling of NaDC3 with OAT1 and OAT3 for three reasons. First, its plasma concentration (8.6 M) (28) is higher than that of glutarate. Second, NaDC3 has a higher affinity for ␣-ketoglutarate than glutarate. Thus, NaDC3 most probably transports more ␣-ketoglutarate than glutarate into the proximal tubule cell. Third, OAT1 and OAT3 have relatively high affinities for C5 dicarboxylates, enabling them to exchange intracellular ␣-ketoglutarate against PAH, ES, and other endogenous and exogenous OA.
